MSc in Finance and Investment

University of Hull, United Kingdom

Over 15 years of in-depth industry experience.

Core Expertise:

Full-cycle private equity fund management, risk control system development, cross-border capital operations, and government-guided fund liaison. Known for a compliance-driven, value-oriented approach across the entire "fundraising–investment–portfolio management–exit" value chain, empowering the full lifecycle of both funds and portfolio projects.

Master's Degree

Durham University, United Kingdom

Former Role:

China International Capital Corporation (CICC)

Experience:

With multiple years of investment banking experience, [I/he/she] has served a number of financial institution headquarters and state-owned listed companies, and been deeply involved in the investment operations of multiple projects.

With over a decade of experience in financial management and capital operations across listed companies (Kingdee International, Wiscom System) and private equity funds. Holds a Bachelor's degree in Accounting. Deeply involved in investor relations, brand strategy, and post-investment exit management of core projects, driving diversified financing strategies and maximizing project value realization.

Pharmacy Doctor, Fudan University,

Research and investment in the field of anti-tumor drugs,

Experiences in consulting and healthcare investment,

Overseas mergers and acquisitions & innovative drug investment

Master's Degree

Durham University, United Kingdom

Former Role:

China International Capital Corporation (CICC)

Experience:

With multiple years of investment banking experience, [I/he/she] has served a number of financial institution headquarters and state-owned listed companies, and been deeply involved in the investment operations of multiple projects.

Master's degree in Investment from Central University of Finance and Economics, and serves as an off-campus graduate advisor. Over ten years of experience in biomedical investment, with backgrounds in the investment department of a listed pharmaceutical company and a central SOE private equity firm. Has led investments and incubations in over 20 projects across innovative drugs and medical devices, with more than 6 exits through IPOs, M&A, and equity transfers. Has initiated and established multiple healthcare funds.

MSc of Biology, Sun Yat-Sen University, Focuses on gene, cell therapy, high-end medical device research and investment, many years of VC/PE investment experience, with > 15 successful investment cases, including 5 IPO projects

Ph.D. in Chemistry

The University of Texas at Austin, U.S.A.

Multi-year cross-border biopharmaceutical investment experience (China & U.S.).

Core Focus:

Innovative drugs, synthetic biology, and other cutting-edge biotechnology sectors.

Additional Background:

Investment experience in the private equity secondary market within the healthcare sector.

Ph.D. in Neurobiology (USTC) and B.E. in Bioengineering (CUMT), offering a unique interdisciplinary background spanning life sciences and engineering. Focuses on PE investment in innovative drugs and high-value medical devices, with multiple closed deals in the sector.

Ph.D. in Life Sciences from Nankai University, specializing in enzyme-catalyzed biosynthesis and nucleic acid aptamers. Authored multiple SCI papers and contributed to several patents and industry standards.